Federal and State Food Safety Information Sharing Act of 2026
HB8430, the Federal and State Food Safety Information Sharing Act of 2026, would amend the Federal Food, Drug, and Cosmetic Act to let the Secretary of Health and Human Services share unredacted FDA food safety information with state, local, Tribal, and territorial authorities that have related public health responsibilities. The bill specifically authorizes sharing of foodborne illness surveillance data, laboratory testing information, inspection results, recall and outbreak distribution lists, consumer complaints, and other information the Secretary believes would help protect the public.
The bill also directs that this information be shared as soon as reasonably practicable and limits further disclosure by recipient authorities unless FDA permission is obtained, except when disclosure is needed to contain a foodborne illness outbreak, conduct a recall, or carry out other state enforcement activities. In addition, the bill makes a conforming change to the FDCA’s general prohibition on disclosure of certain information so that the new sharing authority is expressly carved out from that restriction. Separately, it extends the duration of certain food safety grants from 3 years to 5 years and makes continued funding contingent on a successful program evaluation after the first year where applicable.
If enacted, the bill would modify federal food safety confidentiality rules under the Federal Food, Drug, and Cosmetic Act by creating a new exception allowing FDA to share otherwise protected information with nonfederal public health authorities. It would affect the Secretary of Health and Human Services, FDA, and state, local, Tribal, and territorial agencies involved in foodborne illness response, recalls, inspections, and enforcement. The bill would also lengthen the grant period for food safety enhancement grants and change the conditions under which later-year funding may continue.
Based on the available record, the bill appears to have a generally supportive, practical public health framing, with no recorded votes or committee debate indicating opposition. Its stated purpose is to improve coordination and speed in food safety response, which suggests a consensus-oriented approach focused on outbreak prevention and enforcement efficiency. Because there are no transcripts or votes, there is no documented partisan or stakeholder sentiment beyond the bill’s introduction and referral.
The main potential point of contention is the bill’s authorization to share unredacted FDA information notwithstanding section 301(j) and other laws, regulations, or policies, which could raise confidentiality, privacy, and information-control concerns. Another possible issue is the bill’s allowance for further disclosure by recipient authorities in limited circumstances, which may prompt questions about safeguards and the scope of state enforcement use. The grant extension and evaluation-based funding condition are less controversial on their face, but they do alter federal grant administration and could draw attention from agencies or recipients focused on funding stability and oversight.